Evidence map›Paper›PMID 36630168›Full record

ArticleeLife2023

A novel fold for acyltransferase-3 (AT3) proteins provides a framework for transmembrane acyl-group transfer.

Kahlan E Newman, Sarah N Tindall, Sophie L Mader, Syma Khalid, Gavin H Thomas, Marjan W Van Der Woude

Abstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. AnResearch square · 2026
    Article
  2. Article
  3. Review
  4. Phenotypic and Genomic Analysis ofPlants (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Structure of the human heparan-α-glucosaminidebioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kahlan E Newman *School of Chemistry, University of Southampton, Southampton, United Kingdom.ORCID 0000-0002-2974-528X
Sarah N Tindall *Department of Biology and the York Biomedical Research Institute, University of York, York, United Kingdom.ORCID 0000-0003-0292-1033
Sophie L MaderDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-3011-3319
Syma KhalidDepartment of Biochemistry, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-3694-5044
Gavin H ThomasDepartment of Biology and the York Biomedical Research Institute, University of York, York, United Kingdom.ORCID 0000-0002-9763-1313
Marjan W Van Der WoudeHull York Medical School and the York Biomedical Research Institute, University of York, York, United Kingdom.ORCID 0000-0002-0446-8829

Funding

Biotechnology and Biological Sciences Research Council BB/M011151/1British Heart Foundation PG/16/5/31912
6 · The paper itself

Abstract

Acylation of diverse carbohydrates occurs across all domains of life and can be catalysed by proteins with a membrane bound acyltransferase-3 (AT3) domain (PF01757). In bacteria, these proteins are essential in processes including symbiosis, resistance to viruses and antimicrobials, and biosynthesis of antibiotics, yet their structure and mechanism are largely unknown. In this study, evolutionary co-variance analysis was used to build a computational model of the structure of a bacterial O-antigen modifying acetyltransferase, OafB. The resulting structure exhibited a novel fold for the AT3 domain, which molecular dynamics simulations demonstrated is stable in the membrane. The AT3 domain contains 10 transmembrane helices arranged to form a large cytoplasmic cavity lined by residues known to be essential for function. Further molecular dynamics simulations support a model where the acyl-coA donor spans the membrane through accessing a pore created by movement of an important loop capping the inner cavity, enabling OafB to present the acetyl group close to the likely catalytic resides on the extracytoplasmic surface. Limited but important interactions with the fused SGNH domain in OafB are identified, and modelling suggests this domain is mobile and can both accept acyl-groups from the AT3 and then reach beyond the membrane to reach acceptor substrates. Together this new general model of AT3 function provides a framework for the development of inhibitors that could abrogate critical functions of bacterial pathogens.

Indexed as

AcetyltransferasesBacteriaAcylationProtein Structure, SecondaryAcetyltransferasesacetylationbacteriabiochemistrychemical biologycomputational biologylipopolysaccharidemembrane proteinSalmonella entericasurface polysaccharidessystems biology

Identifiers

PMID36630168
PMCPMC9833829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.